Phenazine‐1‐Carboxylic Acid Inhibits Ferroptosis by Stabilizing EHMT2
The FASEB Journal · 15.11.2026 · 40 (21)
DOI: 10.1096/fj.202602470r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 29.10.2026. Verfasst von Xue Sun und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated 903 Hospital of Zhejiang Sci-Tech University, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China. Hauptthemen laut MEDLINE: Ferroptosis, Histone-Lysine N-Methyltransferase, Phenazines. Die Arbeit nennt 57 Literaturangaben. Gefördert von: Zhejiang Sci-Tech University (ZSTU), Zhejiang Provincial Excellent Funding for Postdoctoral Researchers, Zhejiang Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
Ferroptosis is a regulated form of cell death driven by iron‐dependent lipid peroxidation and implicated in the pathogenesis of various diseases. Identifying ferroptosis inhibitors may therefore provide therapeutic opportunities for these disorders. Here, we identified phenazine‐1‐carboxylic acid (PCA) as a potent ferroptosis inhibitor through high‐throughput screening. Mechanistically, PCA reduced the accumulation of intracellular reactive oxygen species (ROS) and lipid ROS in part by stabilizing the protein level of euchromatic histone‐lysine N‐methyltransferase 2 (EHMT2). PCA also markedly alleviated cisplatin‐induced acute kidney injury (AKI) in mice. These findings identify a previously unrecognized ferroptosis‐suppressive function of PCA and support its further evaluation as a lead compound for ferroptosis‐associated diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Affiliated 903 Hospital of Zhejiang Sci-Tech University, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.
- Zhejiang Provincial Engineering Research Center of New Technologies and Applications for Targeted Therapy of Major Diseases, Zhejiang Sci-Tech University, Hangzhou, China.
- Zhejiang Provincial Key Laboratory of Drug Discovery and Development for Metabolic Diseases, Zhejiang Sci-Tech University, Hangzhou, China.
- Department of Hematology and Oncology, The 903rd Hospital of the Joint Logistic Support Force, Hangzhou, China.
ORCID-Profile: Chaoyi Xia
Förderung
- Zhejiang Sci-Tech University (ZSTU)
- Zhejiang Provincial Excellent Funding for Postdoctoral Researchers
- Zhejiang Provincial Natural Science Foundation of China
- National Natural Science Foundation of China
Zitieren
APA
Sun, X., Chen, Y., Xia, C., Wei, C., Shao, J., Wang, D., Fan, Z., Min, J., Fu, C., & Wang, X. (2026). Phenazine‐1‐Carboxylic Acid Inhibits Ferroptosis by Stabilizing EHMT2. The FASEB Journal, 40(21). https://doi.org/10.1096/fj.202602470r
Vancouver
Sun X, Chen Y, Xia C, Wei C, Shao J, Wang D, et al. Phenazine‐1‐Carboxylic Acid Inhibits Ferroptosis by Stabilizing EHMT2. The FASEB Journal. 2026;40(21). doi:10.1096/fj.202602470r
BibTeX
@article{Sun2026,
author = {Sun, Xue and Chen, Yang and Xia, Chaoyi and Wei, Chong and Shao, Junyi and Wang, Dingyao and Fan, Zixuan and Min, Jingshu and Fu, Caiyun and Wang, Xi},
title = {Phenazine‐1‐Carboxylic Acid Inhibits Ferroptosis by Stabilizing EHMT2},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {21},
doi = {10.1096/fj.202602470r}
}
EUVIMED